Pharma Journalist -

Syndax Pharmaceuticals that is developing entinostat and SNDX-6352 in multiple cancer indications declared collaboration with a member of Roche Group, Genentech to evaluate  the…
Read More...

Kalorama states that IVD industry has embarked on  an approach to advance IVD innovations in Sepsis. Sepsis is characterized by tedious detection in its early stages as  fever,…
Read More...

Pharmaceutical company ALK introduction of its sublingual allergy immunotherapy (SLIT) tablet ODACTRA set to be rolled out for US Patients in the age group of 18- 65 years afflicted…
Read More...

After the Bone, Reproductive and Urologic Drugs Advisory Committee ("BRUDAC") of the U.S. Food and Drug Administration ("FDA") voted six in favor and thirteen against the benefit/risk…
Read More...

Braeburn Pharmaceutical asserts completion of its $110- million mezzanine financing among a few others like Avista Capital Partners, RA Capital Management, New Leaf Venture Partners,…
Read More...

Biodegradable balloon spacers, BioProtect announces the launch of Clinical Trial followed by the FDA approval for Investigational Device Exemption in November , 2017 that seeks to…
Read More...

AstraZeneca declared that BYDUREON BCise was now available in pharmacies across the U.S. An injectable suspension 2mg sanctioned by the U.S FDA for adults afflicted with Type-2 Diabetes…
Read More...

Artificial intelligence imaging and workflow software, Viz.ai announced CE Mark of its Direct-to-intervention system, ContaCT that adopts to interpret brain CTs intimating a specialist…
Read More...

Clinical stage biopharmaceutical company, SAB Biotherapeutics declared its phase 1 Clinical Trial results for treating MERS, a study that was undertaken by National Institutes of…
Read More...

Having forayed into development of minimally invasive solutions for symptomatic uterine fibroids, women’s healthcare company, Gynesonics announced the results for their pivotal IDE…
Read More...